Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
Doxorubicin
×
Clear all
Filters
3
NCT03517449
2025-06-15
MK-3475-775
Eisai Inc.
Phase 3
Completed
827 enrolled
18 charts
1 FDA
NCT01767155
2018-07-31
ZoptEC
AEterna Zentaris
Phase 3
Completed
511 enrolled
16 charts
NCT00883116
2017-03-09
IXAMPLE2
R-Pharm
Phase 3
Terminated
551 enrolled
13 charts